Loxapine Capsule
Product Images NDC 64850-892

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 64850-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Elite Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Loxapine Base Structural Formula (Loxapine 01)

Loxapine base is a chemical compound used as an antipsychotic medication for the treatment of schizophrenia.*

FDA Label Image

Loxapine Succinate 5mg (Loxapine 02)

This text provides instructions for the usual dosage, storage, and dispensation of Loxapine Succinate capsules manufactured by Elite Laboratories, Inc. It also includes the NDC number and expiration date. Store the medication in a tight container in a controlled room temperature environment. The insert for the prescribing information should be consulted for complete dosing details.*

FDA Label Image

Loxapine Succinate 10mg (Loxapine 03)

This is a label of a medication called Loxapine Succinate manufactured by Elite Laboratories. The label provides instructions on the usual dosage, storage requirements, dispensing, and the need to keep the medication out of the reach of children. The medication comes in a capsule form and each capsule contains 10 mg of Loxapine.*

FDA Label Image

Loxapine Succinate 25mg (Loxapine 04)

This is a description for Loxapine Capsules, USP. The usual dosage is not provided and must be referenced in the insert. It should be stored in a tight container at a temperature of 20° to 25°C (68° to 77°F) and out of reach of children. It contains 100 capsules, each capsule containing Loxapine Succinate equivalent to 25 mg Loxapine. The capsules are manufactured by Elite Laboratories, Inc. with a control number of NDC 64850-892-01. The description also notes the requirement of a child-resistant closure.*

FDA Label Image

Loxapine Succinate 50mg (Loxapine 05)

This text provides dosage instructions, storage information, and manufacturer details for a medication containing Loxapine Succinate in capsule form. It advises to store the medication in a tight container with a child-resistant closure within USP defined temperature range. The medication comes in 100 capsules and should be kept away from children. Contact information for the manufacturer, Elite Laboratories, Inc., is also given.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.